Respiratory
1 drug is in development for Chronic Obstructive Pulmonary Disease.
- Companies
- 1
- Clinical trials
- 33
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Chronic Obstructive Pulmonary Disease pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| verekitug | Upstream Bio, Inc. (UPB) |
About this indication
Chronic Obstructive Pulmonary Disease context
Respiratory·MeSH: Pulmonary Disease, Chronic Obstructive (D029424)
Also known as: COAD, COPD, Chronic Obstructive Airway Disease, Chronic Obstructive Lung Disease, Chronic Obstructive Pulmonary Diseases
Prevalence
6000.0 / 100K
Incidence
200.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Chronic Obstructive Pulmonary Disease?
BioSniper tracks 1 drug in development for Chronic Obstructive Pulmonary Disease across 1 company.
How many clinical trials target Chronic Obstructive Pulmonary Disease?
There are 33 clinical trials targeting Chronic Obstructive Pulmonary Disease tracked by BioSniper.
What is the prevalence of Chronic Obstructive Pulmonary Disease?
The estimated prevalence of Chronic Obstructive Pulmonary Disease is approximately 6000.0 per 100,000 population.